Fmoc-tBu-D-Gly-OH is an Fmoc-protected, tert-butyl-protected derivative of D-glycine, belonging to the glycine amino acid class with a small side chain (hydrogen) and a stereochemically specified D configuration. The molecule contains a free carboxylic acid functional group while the amino functionality is masked by the Fmoc carbamate, and the tert-butyl protection corresponds to a tert-butyl ester-type masking of the carboxylate/acid functionality as indicated by the tBu substituent, together providing chemoselectivity during multi-step synthesis. In peptide chemistry and related solid-phase or stepwise coupling workflows, this protected amino acid derivative functions as a building block that can be deprotected and coupled to form peptide bonds while maintaining orthogonal protection for controlled sequence assembly and analytical characterization of intermediates.
CAT No: CP26615
CAS No:198543-64-5
Synonyms/Alias:Fmoc-D-tert-leucine;198543-64-5;Fmoc-D-Tle-OH;Fmoc-D-alpha-tert-butyl-Gly-OH;PubChem15622;AC1LJQP3;SCHEMBL13946516;CTK8C6802;MolPort-006-705-641;ZINC4899519;AKOS025289356;CF-1279;RTR-009228;AK170047;AN-30079;TR-009228;FT-0643850;I14-44296;D-Valine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-3-methyl-;(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3,3-dimethyl-butanoicacid;(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3,3-dimethylbutanoicacid;(2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3,3-dimethylbutanoicacid
Fmoc-tBu-D-Gly-OH is an Fmoc-protected, tert-butyl-protected D-glycine amino acid derivative designed for peptide chemistry. The molecule contains an Fmoc carbamate on the amino functionality, a carboxylic acid as the C-terminal handle, and a tert-butyl group on the side-chain carbon that functions as a steric and protecting element while maintaining the D-configuration at the chiral center. The presence of the acid enables straightforward coupling chemistry, whereas the Fmoc group supports orthogonal deprotection under base-promoted conditions typical of solid-phase and solution-phase peptide synthesis. The tBu substituent influences steric accessibility and can be removed under acidolysis, allowing downstream conversion to less hindered functional motifs for synthetic elaboration and structure-directed studies.
1. Peptide Synthesis
Fmoc-tBu-D-Gly-OH serves as a protected amino acid building block for peptide assembly in both solid-phase peptide synthesis and solution-phase coupling workflows. The Fmoc carbamate provides an N-protection strategy compatible with standard peptide coupling and iterative chain elongation, while the free carboxylic acid participates in amide bond formation using common peptide coupling reagents. The D-stereochemistry can be used to introduce stereochemical bias into peptide backbones, and the tert-butyl-protected glycine motif can modulate local conformation and reactivity during synthesis. The resulting peptides can be prepared as protected intermediates for subsequent deprotection, side-chain unveiling, or incorporation into larger peptide constructs for biochemical research and materials-oriented peptide engineering.
2. Peptidomimetics Construction
Fmoc-tBu-D-Gly-OH supports peptidomimetic and constrained scaffold design where amino acid stereochemistry and steric elements are used to tune molecular recognition. The chiral D-center and the tert-butyl substituent can be leveraged to control spatial presentation of backbone atoms and side-chain bulk, which is relevant when constructing analogs intended for structure-activity relationship studies. The Fmoc-protected nitrogen enables sequential assembly into oligomers, while the carboxylic acid functionality allows conversion into amide-linked fragments that maintain defined stereochemical patterns. Downstream deprotection and functional group adjustment can generate less hindered intermediates for cyclization, derivatization, or incorporation into heteroatom-containing motifs used in synthetic organic chemistry and medicinal chemistry research.
3. Chiral Building Block Development
Fmoc-tBu-D-Gly-OH functions as a chiral amino acid intermediate for stereoselective synthesis routes that require D-glycine-derived stereochemical control. The Fmoc group provides a robust handle for protecting-group strategies during multi-step synthesis, while the tert-butyl-protected side-chain element can be used to manage chemoselectivity when preparing derivatives that demand controlled exposure of reactive functionalities. The free carboxylic acid enables conversion into activated esters, amides, or coupling-ready forms that preserve stereochemical integrity through downstream transformations. The compound's defined stereochemistry and orthogonal protection pattern make it suitable for manufacturing intermediate preparation where consistent chiral input is required for fine chemical synthesis and applied peptide scaffold production.
4. Side-Chain Functionalization
Fmoc-tBu-D-Gly-OH can be applied to side-chain functionalization workflows that start from a protected glycine framework and proceed through controlled deprotection and derivatization. The tert-butyl group provides a removable steric/protection element that can be used to regulate access to the side-chain region during peptide coupling and intermediate handling. The combination of an Fmoc-protected amine and a free carboxylic acid supports sequential transformations where N-deprotection and side-chain unveiling can be timed to match the needs of the target structure. The resulting functionalized amino acid derivatives or peptide fragments can be used to generate modified biomolecular probes, enzyme substrate analogs, or stereochemically defined intermediates for chemical manufacturing and specialty chemical production.
5. Chemical Biology Probes
Fmoc-tBu-D-Gly-OH is suitable for chemical biology research requiring stereochemically defined peptide fragments and amino acid-derived linkers. The protected amino acid format enables incorporation into peptide sequences used to probe binding interfaces, enzyme recognition elements, or conformational preferences in biomolecular systems. The D-configuration and steric tert-butyl element can introduce resistance to certain proteolytic processing and can influence interaction geometry, supporting the construction of stable peptide analogs for mechanistic studies. The Fmoc-compatible synthesis strategy also facilitates generation of labeled or conjugatable peptide intermediates after deprotection steps, enabling downstream coupling to tags, affinity handles, or other functional moieties used in biomolecule modification and analytical research.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.